KAILERA THERAPEUTICS INC

Historical 13F Holders

Symbol
KLRA
CUSIP
482931102
All holders as of
Q2 2026
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 482931102 since 12/18/2024, largest first.

Filer % of Class Filed
BCPE Perseus Investor, LP 13D 20.3% 4/23/2026
Event 4/16/2026
BCLS Fund IV Investments, L.P. 13D 17.4% 4/23/2026
Event 4/16/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 13G 8.9% 8/5/2026
Event 6/30/2026
RTW Investments, LP 13G
8.3% 8/14/2026
Event 6/30/2026
Canada Pension Plan Investment Board 13G
5.6% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 59.6 k $681 k
2026 Q2 102 117 M $2.58 B